본문 바로가기

Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profiles

문서 유형
연구출판물 · 학술지 논문
등재
Nature IndexSCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
NATURE COMMUNICATIONS15(1) · 2024
피인용
Web of Science 11Scopus 12
FWCI (Scopus)
0.99
JCR IF
JCR 2023 14.7
ISSN
2041-1723

저자

  1. 정용담제1저자Pusan Natl Univ, Dept Math, Pusan 46241, South Korea
  2. Hart, William S.Nagoya Univ, Grad Sch Sci, Div Nat Sci, Interdisciplinary Biol Lab iBLab, Nagoya, Japan
  3. Thompson, Robin N.Univ Oxford, Math Inst, Oxford OX2 6GG, England
  4. Ishikane, MasahiroDis Control & Prevent Ctr, Natl Ctr Global Hlth & Med, Tokyo, Japan
  5. Nishiyama, TakaraNagoya Univ, Grad Sch Sci, Div Nat Sci, Interdisciplinary Biol Lab iBLab, Nagoya, Japan
  6. 박형기Nagoya Univ, Grad Sch Sci, Div Nat Sci, Interdisciplinary Biol Lab iBLab, Nagoya, Japan
  7. Iwamoto, NorikoDis Control & Prevent Ctr, Natl Ctr Global Hlth & Med, Tokyo, Japan
  8. Sakurai, AyanaDis Control & Prevent Ctr, Natl Ctr Global Hlth & Med, Tokyo, Japan
  9. Suzuki, MichiyoDis Control & Prevent Ctr, Natl Ctr Global Hlth & Med, Tokyo, Japan
  10. Aihara, KazuyukiUniv Tokyo, Univ Tokyo Inst Adv Study, Int Res Ctr Neurointelligence, Tokyo, Japan
  11. Watashi, KoichiNatl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo, Japan
  12. op de Coul, ElineNatl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
  13. Ohmagari, NorioDis Control & Prevent Ctr, Natl Ctr Global Hlth & Med, Tokyo, Japan
  14. Wallinga, JaccoNatl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
  15. Iwami, Shingo교신저자Nagoya Univ, Grad Sch Sci, Div Nat Sci, Interdisciplinary Biol Lab iBLab, Nagoya, Japan
  16. Miura, Fuminari교신저자Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands

초록

The global outbreak of mpox in 2022 and subsequent sporadic outbreaks in 2023 highlighted the importance of nonpharmaceutical interventions such as case isolation. Individual variations in viral shedding dynamics may lead to either premature ending of isolation for infectious individuals, or unnecessarily prolonged isolation for those who are no longer infectious. Here, we developed a modeling framework to characterize heterogeneous mpox infectiousness profiles – specifically, when infected individuals cease to be infectious – based on viral load data. We examined the potential effectiveness of three different isolation rules: a symptom-based rule (the current guideline in many countries) and rules permitting individuals to stop isolating after either a fixed duration or following tests that indicate that they are no longer likely to be infectious. Our analysis suggests that the duration of viral shedding ranges from 23 to 50 days between individuals. The risk of infected individuals ending isolation too early was estimated to be 8.8% (95% CI: 6.7–10.5) after symptom clearance and 5.4% (95% CI: 4.1–6.7) after 3 weeks of isolation. While these results suggest that the current standard practice for ending isolation is effective, we found that unnecessary isolation following the infectious period could be reduced by adopting a testing-based rule.

키워드

VIRUS

식별자

Scopus EID
2-s2.0-85202061129
WoS UID
001304522300028